Growth Metrics

Neuronetics (STIM) Liabilities and Shareholders Equity (2017 - 2026)

Neuronetics has reported Liabilities and Shareholders Equity over the past 10 years, most recently at $125.4 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 11.65% to $125.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $547.1 million through Mar 2026, up 20.56% year-over-year, with the annual reading at $141.6 million for FY2025, 0.46% changed from the prior year.
  • Liabilities and Shareholders Equity was $125.4 million for Q1 2026 at Neuronetics, down from $141.6 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $145.5 million in Q3 2025 and troughed at $74.1 million in Q3 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $119.2 million (2022), against an average of $118.0 million.
  • Year-over-year, Liabilities and Shareholders Equity decreased 22.01% in 2023 and then skyrocketed 96.26% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $116.9 million in 2022, then decreased by 0.9% to $115.8 million in 2023, then increased by 21.65% to $140.9 million in 2024, then rose by 0.46% to $141.6 million in 2025, then dropped by 11.38% to $125.4 million in 2026.
  • Per Business Quant, the three most recent readings for STIM's Liabilities and Shareholders Equity are $125.4 million (Q1 2026), $141.6 million (Q4 2025), and $145.5 million (Q3 2025).